Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment

Journal: The American Journal on Addictions
Credit: 1.0 AMA PRA Category 1 Credits^TM
Release Date: June 15, 2023

Activity Disclosures

This study was support in part by the University of Oklahoma Health Sciences Center, Oklahoma Tobacco Settlement Endowment Trust(TSET) contract # R22‐03 and NCI grant P30CA2255520 awarded to the Stephenson Cancer Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

This activity underwent peer review in line with standards of editorial integrity and publication ethics. Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of John Wiley & Sons, Inc. and the American Academy of Addiction Psychiatry (AAAP). John Wiley & Sons, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.    This activity is designed to be completed within 1 hour. To successfully earn credit, participants must complete the activity during the valid credit period, which is up to two years from initial publication. Additionally, up to 3 attempts and a score of 100% or better is needed to pass the post test.